Merit Medical Systems, Inc.  

(Public, NASDAQ:MMSI)   Watch this stock  
Find more results for MMSI
26.60
+0.60 (2.31%)
After Hours: 26.60 0.00 (0.00%)
Dec 9, 4:30PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 26.10 - 26.80
52 week 15.47 - 26.80
Open 26.20
Vol / Avg. 328,138.00/290,289.00
Mkt cap 1.20B
P/E 62.11
Div/yield     -
EPS 0.43
Shares 44.59M
Beta 0.93
Inst. own 93%
Feb 20, 2017
Q4 2016 Merit Medical Systems Inc Earnings Release (Estimated) - 12:00AM EST - Add to calendar
Nov 30, 2016
Merit Medical Systems Inc at Piper Jaffray Healthcare Conference
Nov 17, 2016
Merit Medical Systems Inc at Canaccord Genuity Med Tech Conference
Nov 16, 2016
Merit Medical Systems Inc at Jefferies Healthcare Conference
Nov 10, 2016
Merit Medical Systems Inc at Needham Med Tech 1x1 Conference
Oct 26, 2016
Q3 2016 Merit Medical Systems Inc Earnings Call
Oct 26, 2016
Q3 2016 Merit Medical Systems Inc Earnings Release
Sep 14, 2016
Merit Medical Systems Inc at Credit Suisse Small & Mid Cap Conference
Sep 13, 2016
Merit Medical Systems Inc at Morgan Stanley Global Healthcare Conference
Sep 12, 2016
Merit Medical Systems Inc at CL King & Associates Best Ideas Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin 0.62% 4.39%
Operating margin 1.90% 6.92%
EBITD margin - 13.83%
Return on average assets 0.45% 3.12%
Return on average equity 0.81% 5.28%
Employees 3,754 -
CDP Score - -

Address

1600 W Merit Pkwy
SOUTH JORDAN, UT 84095-2416
United States - Map
+1-801-2531600 (Phone)
+1-801-2531652 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Merit Medical Systems, Inc. is a designer, developer, manufacturer and marketer of medical devices used in an array of interventional and diagnostic procedures. The Company operates in two segments: cardiovascular and endoscopy. Its cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases; embolotherapeutic products, and cardiac rhythm management and electrophysiology (CRM/EP) devices. Its endoscopy segment consists of gastroenterology and pulmonology medical devices, which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. Its products are used in various clinical areas, such as diagnostic and interventional cardiology; interventional radiology; vascular, general and thoracic surgery; interventional pulmonology; interventional nephrology; oncology, and pain management.

Officers and directors

Fred P. Lampropoulos Chairman of the Board, President, Chief Executive Officer
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Bernard Birkett Chief Financial Officer
Bio & Compensation  - Reuters
Ronald A. Frost Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
David M. Liu Director
Bio & Compensation  - Reuters
Kent W. Stanger Director
Age: 60
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
A. Scott Anderson Independent Director
Age: 68
Bio & Compensation  - Reuters
Richard W. Edelman Independent Director
Age: 74
Bio & Compensation  - Reuters
Nolan E. Karras Independent Director
Age: 70
Bio & Compensation  - Reuters